IBS-C Drugs Market Report

Global and Region IBS-C Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：151
  • REPORT CODE：GMM996143
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of IBS-C Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of IBS-C Drugsmarket, defines the market attractiveness level of IBS-C Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of IBS-C Drugs industry, describes the types of IBS-C Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global IBS-C Drugs market and the development prospects and opportunities of IBS-C Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global IBS-C Drugs market in Chapter 13.

    By Player:

    • Bama-Geve, SLU

    • Astellas Pharmaceuticals

    • Yuhan Corp

    • Synergy Pharmaceuticals

    • Ironwood Pharmaceuticals Inc

    • The Menarini Group

    • Salix Pharmaceuticals Ltd

    • Ferring BV

    • Ardelyx Inc

    • Catalent Pharmaceuticals Solutions

    • Astrazeneca Plc

    • Norgine BV

    • Nestle

    • Ono Pharmaceutical CO LTD

    • Prometheus Laboratories Inc

    • Abbott Laboratories

    • Teva Pharmaceutical Industries

    • Actavis Nordic A/S

    • Synthetic Biologics Inc

    • Novartis Pharma Ag

    • Sucampo Pharmaceuticals

    • Albireo Pharma Inc

    By Type:

    • Linaclotide

    • Lubiprostone

    • Osmotic Laxatives

    • Stimulant Laxatives

    • Other

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 IBS-C Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 IBS-C Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 IBS-C Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 IBS-C Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise IBS-C Drugs Market Analysis and Outlook to 2022

    • 7.1 Global IBS-C Drugs Consumption (2017-2022)

    • 7.2 United States IBS-C Drugs Consumption (2017-2022)

    • 7.3 Europe IBS-C Drugs Consumption (2017-2022)

    • 7.4 China IBS-C Drugs Consumption (2017-2022)

    • 7.5 Japan IBS-C Drugs Consumption (2017-2022)

    • 7.6 India IBS-C Drugs Consumption (2017-2022)

    • 7.7 South Korea IBS-C Drugs Consumption (2017-2022)

    8 Region and Country-wise IBS-C Drugs Market Analysis and Outlook to 2028

    • 8.1 Global IBS-C Drugs Consumption Forecast (2022-2028)

    • 8.2 United States IBS-C Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe IBS-C Drugs Consumption Forecast (2022-2028)

    • 8.4 China IBS-C Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan IBS-C Drugs Consumption Forecast (2022-2028)

    • 8.6 India IBS-C Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea IBS-C Drugs Consumption Forecast (2022-2028)

    9 Global IBS-C Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global IBS-C Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Linaclotide Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lubiprostone Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Osmotic Laxatives Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Stimulant Laxatives Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global IBS-C Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global IBS-C Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global IBS-C Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Lubiprostone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Osmotic Laxatives Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Stimulant Laxatives Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global IBS-C Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global IBS-C Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global IBS-C Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global IBS-C Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 IBS-C Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global IBS-C Drugs Market Competitive Analysis

    • 14.1 Bama-Geve, SLU

      • 14.1.1 Bama-Geve, SLU Company Details

      • 14.1.2 Bama-Geve, SLU IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bama-Geve, SLU IBS-C Drugs Product and Service

    • 14.2 Astellas Pharmaceuticals

      • 14.2.1 Astellas Pharmaceuticals Company Details

      • 14.2.2 Astellas Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Astellas Pharmaceuticals IBS-C Drugs Product and Service

    • 14.3 Yuhan Corp

      • 14.3.1 Yuhan Corp Company Details

      • 14.3.2 Yuhan Corp IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Yuhan Corp IBS-C Drugs Product and Service

    • 14.4 Synergy Pharmaceuticals

      • 14.4.1 Synergy Pharmaceuticals Company Details

      • 14.4.2 Synergy Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Synergy Pharmaceuticals IBS-C Drugs Product and Service

    • 14.5 Ironwood Pharmaceuticals Inc

      • 14.5.1 Ironwood Pharmaceuticals Inc Company Details

      • 14.5.2 Ironwood Pharmaceuticals Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Ironwood Pharmaceuticals Inc IBS-C Drugs Product and Service

    • 14.6 The Menarini Group

      • 14.6.1 The Menarini Group Company Details

      • 14.6.2 The Menarini Group IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 The Menarini Group IBS-C Drugs Product and Service

    • 14.7 Salix Pharmaceuticals Ltd

      • 14.7.1 Salix Pharmaceuticals Ltd Company Details

      • 14.7.2 Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Salix Pharmaceuticals Ltd IBS-C Drugs Product and Service

    • 14.8 Ferring BV

      • 14.8.1 Ferring BV Company Details

      • 14.8.2 Ferring BV IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Ferring BV IBS-C Drugs Product and Service

    • 14.9 Ardelyx Inc

      • 14.9.1 Ardelyx Inc Company Details

      • 14.9.2 Ardelyx Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Ardelyx Inc IBS-C Drugs Product and Service

    • 14.10 Catalent Pharmaceuticals Solutions

      • 14.10.1 Catalent Pharmaceuticals Solutions Company Details

      • 14.10.2 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Product and Service

    • 14.11 Astrazeneca Plc

      • 14.11.1 Astrazeneca Plc Company Details

      • 14.11.2 Astrazeneca Plc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Astrazeneca Plc IBS-C Drugs Product and Service

    • 14.12 Norgine BV

      • 14.12.1 Norgine BV Company Details

      • 14.12.2 Norgine BV IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Norgine BV IBS-C Drugs Product and Service

    • 14.13 Nestle

      • 14.13.1 Nestle Company Details

      • 14.13.2 Nestle IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Nestle IBS-C Drugs Product and Service

    • 14.14 Ono Pharmaceutical CO LTD

      • 14.14.1 Ono Pharmaceutical CO LTD Company Details

      • 14.14.2 Ono Pharmaceutical CO LTD IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Ono Pharmaceutical CO LTD IBS-C Drugs Product and Service

    • 14.15 Prometheus Laboratories Inc

      • 14.15.1 Prometheus Laboratories Inc Company Details

      • 14.15.2 Prometheus Laboratories Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Prometheus Laboratories Inc IBS-C Drugs Product and Service

    • 14.16 Abbott Laboratories

      • 14.16.1 Abbott Laboratories Company Details

      • 14.16.2 Abbott Laboratories IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Abbott Laboratories IBS-C Drugs Product and Service

    • 14.17 Teva Pharmaceutical Industries

      • 14.17.1 Teva Pharmaceutical Industries Company Details

      • 14.17.2 Teva Pharmaceutical Industries IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Teva Pharmaceutical Industries IBS-C Drugs Product and Service

    • 14.18 Actavis Nordic A/S

      • 14.18.1 Actavis Nordic A/S Company Details

      • 14.18.2 Actavis Nordic A/S IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Actavis Nordic A/S IBS-C Drugs Product and Service

    • 14.19 Synthetic Biologics Inc

      • 14.19.1 Synthetic Biologics Inc Company Details

      • 14.19.2 Synthetic Biologics Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Synthetic Biologics Inc IBS-C Drugs Product and Service

    • 14.20 Novartis Pharma Ag

      • 14.20.1 Novartis Pharma Ag Company Details

      • 14.20.2 Novartis Pharma Ag IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Novartis Pharma Ag IBS-C Drugs Product and Service

    • 14.21 Sucampo Pharmaceuticals

      • 14.21.1 Sucampo Pharmaceuticals Company Details

      • 14.21.2 Sucampo Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Sucampo Pharmaceuticals IBS-C Drugs Product and Service

    • 14.22 Albireo Pharma Inc

      • 14.22.1 Albireo Pharma Inc Company Details

      • 14.22.2 Albireo Pharma Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Albireo Pharma Inc IBS-C Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of IBS-C Drugs

    • Figure IBS-C Drugs Picture

    • Table Global IBS-C Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global IBS-C Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global IBS-C Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global IBS-C Drugs Consumption by Country (2017-2022)

    • Figure United States IBS-C Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe IBS-C Drugs Consumption and Growth Rate (2017-2022)

    • Figure China IBS-C Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan IBS-C Drugs Consumption and Growth Rate (2017-2022)

    • Figure India IBS-C Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea IBS-C Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global IBS-C Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Linaclotide Consumption and Growth Rate (2017-2022)

    • Figure Global Lubiprostone Consumption and Growth Rate (2017-2022)

    • Figure Global Osmotic Laxatives Consumption and Growth Rate (2017-2022)

    • Figure Global Stimulant Laxatives Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lubiprostone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Osmotic Laxatives Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stimulant Laxatives Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global IBS-C Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global IBS-C Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Bama-Geve, SLU (Foundation Year, Company Profile and etc.)

    • Table Bama-Geve, SLU IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bama-Geve, SLU IBS-C Drugs Product and Service

    • Table Astellas Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharmaceuticals IBS-C Drugs Product and Service

    • Table Yuhan Corp (Foundation Year, Company Profile and etc.)

    • Table Yuhan Corp IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yuhan Corp IBS-C Drugs Product and Service

    • Table Synergy Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Synergy Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synergy Pharmaceuticals IBS-C Drugs Product and Service

    • Table Ironwood Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Ironwood Pharmaceuticals Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ironwood Pharmaceuticals Inc IBS-C Drugs Product and Service

    • Table The Menarini Group (Foundation Year, Company Profile and etc.)

    • Table The Menarini Group IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table The Menarini Group IBS-C Drugs Product and Service

    • Table Salix Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)

    • Table Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Salix Pharmaceuticals Ltd IBS-C Drugs Product and Service

    • Table Ferring BV (Foundation Year, Company Profile and etc.)

    • Table Ferring BV IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring BV IBS-C Drugs Product and Service

    • Table Ardelyx Inc (Foundation Year, Company Profile and etc.)

    • Table Ardelyx Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ardelyx Inc IBS-C Drugs Product and Service

    • Table Catalent Pharmaceuticals Solutions (Foundation Year, Company Profile and etc.)

    • Table Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Catalent Pharmaceuticals Solutions IBS-C Drugs Product and Service

    • Table Astrazeneca Plc (Foundation Year, Company Profile and etc.)

    • Table Astrazeneca Plc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astrazeneca Plc IBS-C Drugs Product and Service

    • Table Norgine BV (Foundation Year, Company Profile and etc.)

    • Table Norgine BV IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Norgine BV IBS-C Drugs Product and Service

    • Table Nestle (Foundation Year, Company Profile and etc.)

    • Table Nestle IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nestle IBS-C Drugs Product and Service

    • Table Ono Pharmaceutical CO LTD (Foundation Year, Company Profile and etc.)

    • Table Ono Pharmaceutical CO LTD IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ono Pharmaceutical CO LTD IBS-C Drugs Product and Service

    • Table Prometheus Laboratories Inc (Foundation Year, Company Profile and etc.)

    • Table Prometheus Laboratories Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prometheus Laboratories Inc IBS-C Drugs Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories IBS-C Drugs Product and Service

    • Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries IBS-C Drugs Product and Service

    • Table Actavis Nordic A/S (Foundation Year, Company Profile and etc.)

    • Table Actavis Nordic A/S IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actavis Nordic A/S IBS-C Drugs Product and Service

    • Table Synthetic Biologics Inc (Foundation Year, Company Profile and etc.)

    • Table Synthetic Biologics Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synthetic Biologics Inc IBS-C Drugs Product and Service

    • Table Novartis Pharma Ag (Foundation Year, Company Profile and etc.)

    • Table Novartis Pharma Ag IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Pharma Ag IBS-C Drugs Product and Service

    • Table Sucampo Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Sucampo Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sucampo Pharmaceuticals IBS-C Drugs Product and Service

    • Table Albireo Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Albireo Pharma Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Albireo Pharma Inc IBS-C Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US